Advanced search
Publication Cover
Current Medical Research and Opinion Volume 37, 2021 - Issue 11
Submit an article Journal homepage
5,205
Views
15
CrossRef citations to date
0
Altmetric
Hematology

Comparative effectiveness of pegcetacoplan versus ravulizumab in patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a matching-adjusted indirect comparison

Rachel H. Bhaka Analysis Group, Inc, Boston, MA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4027-647X
ORCID Icon,
Nikita Mody-Patelb Apellis Pharmaceuticals, Inc, Waltham, MA, USA
,
Scott B. Baverb Apellis Pharmaceuticals, Inc, Waltham, MA, USA
,
Colin Kunzweilera Analysis Group, Inc, Boston, MA, USA
,
Christopher W. Yeea Analysis Group, Inc, Boston, MA, USA
,
Sanjana Sundaresana Analysis Group, Inc, Boston, MA, USA
,
Natalia Swartza Analysis Group, Inc, Boston, MA, USA
,
Mei Sheng Duha Analysis Group, Inc, Boston, MA, USA
,
Sangeeta Krishnanb Apellis Pharmaceuticals, Inc, Waltham, MA, USA
&
Sujata P. Sardab Apellis Pharmaceuticals, Inc, Waltham, MA, USA
 show all
Pages 1913-1923 | Received 26 Apr 2021, Accepted 14 Aug 2021, Published online: 03 Sep 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.